-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Guardant Health, Raises Price Target to $115

Benzinga·01/05/2026 17:00:25
语音播报
Guggenheim analyst Subbu Nambi maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $85 to $115.